Hikal Share Price Target 2026, 2027, 2028, 2029, 2030:- Hikal was established in 1988 as a trusted partner to pharmaceutical companies in the fields of pharmaceuticals, biotechnology, agrochemicals, and specialty chemicals. They provide world-class functional, intermediate, and research & development resources and solutions in a safe, secure, and confidential manner.
Therefore, in this article, we attempt to give a new perspective to Hikal stocks using technical and fundamental analysis.
Hikal Share Price Target 2026
Hikal’s superior infrastructure has been tested and approved by internationally recognized organizations such as the USFDA. Hikal is a company built on sustainable relationships.
They are committed to providing value as a long-term partner. Through this commitment, they have earned the respect and recognition of some of the world’s leading companies.
The initial share price target for Hikal in 2026 will be around ₹215. For the second Hikal target, the stock price will be ₹225.
Hikal Share Price Target 2026 Table
| Year | Hikal Share Price Target 2026 |
| First Target 2026 | Rs 215 |
| Second Target 2026 | Rs 225 |
Hikal Share Price Target 2027
Hikal is engaged in research and development, as well as the production and sale of fine chemicals in the pharmaceutical and agrochemical industries. The company collaborates with innovative firms and provides solutions for contract research, optimization, and custom manufacturing. Its personnel have extensive experience managing various projects. Research and development is a central focus for Hikal, and they place a high priority on investing in world-class scientists and laboratory equipment.
Their R&D team is overseen by a scientific advisory board composed of distinguished scientists. They have an impressive track record in research and development.
Their scientists have published numerous books and obtained patents. They have developed several new and cost-effective processes for many known APIs (Active Pharmaceutical Ingredients). The initial share price target for Hikal in 2027 will be ₹240, while the second price target will be ₹250.
Hikal Share Price Target 2027 Table
| Year | Hikal Share Price Target 2027 |
| First Target 2027 | Rs 240 |
| Second Target 2027 | Rs 250 |
Hikal Share Price Target 2028
Hikal provides molecules for contract-based research and is a preferred partner for leading international companies at various stages of drug discovery and development. Supported by modern equipment and a team of experienced scientists, they focus on research involving new molecules.
The company has a successful history of developing processes that do not break down and can be scaled up from the laboratory to kilogram scale and eventually to commercial scale.
Its engineering expertise enables it to effectively set up chemical plants, control multiple processes, and develop solutions that comply with strict quality and safety guidelines. The initial share price target for Hikal in 2028 will be ₹270, while the second target price will be ₹290.
Hikal Share Price Target 2028 Table
| Year | Hikal Share Price Target 2028 |
| First Target 2028 | Rs 270 |
| Second Target 2028 | Rs 290 |
Hikal Share Price Target 2029
Hikal has developed a method to ensure innovation. These processes include internal process analysis, identification, and quantification of contaminants.
Custom manufacturing also optimizes the production of medium-sized essential materials for pharmaceutical and chemical companies worldwide. Its intermediate drugs are used in Phase 1, Phase 2, and Phase 3 clinical trials, as well as in new medicines used in commercial treatments.
The first share price target for Hikal in 2029 will be ₹310, and the second target price for the financial year 2025 will be approximately ₹330.
Hikal Share Price Target 2029 Table
| Year | Hikal Share Price Target 2029 |
| First Target 2029 | Rs 310 |
| Second Target 2029 | Rs 330 |
Hikal Share Price Target 2030
Hikal is a dedicated partner in the global pharmaceutical industry, supporting the pharmaceutical sector from the early stages of leadership to the introduction of new chemical ventures.
Hikal’s expertise covers the entire spectrum, from traditional mixtures to complex chiral chemicals, and is backed by state-of-the-art analytical resources. They are the preferred choice for the world’s leading crop protection companies. International companies utilize their expertise in developing molecule-free processes and analytical methods.
The initial share price target for Hikal in 2030 will be ₹350, and the second target price will be ₹370 by the end of the decade.
Hikal Share Price Target 2030 Table
| Year | Hikal Share Price Target 2030 |
| First Target 2030 | Rs 350 |
| Second Target 2030 | Rs 370 |
Future Prospects of Hikal Share
Hikal has signed a multi-year contract with a world-renowned pharmaceutical company. This contract covers the development and provision of a specific API portfolio over a period of 10 years. Development will begin this year, and sales of the products will commence following successful development and crop sales.
Through this agreement, Hikal is entering the chemicals and products sector, thereby strengthening its vertical in animal health. To implement these APIs, Hikal and its customer will jointly invest in establishing various production facilities at their Panoli site in Gujarat.
Hikal Share Price Target F.A.Q.
– Where is Hikal’s headquarters located?
Hikal’s headquarters is located in Navi Mumbai, India.
– Who is the founder and executive chairman of Hikal?
Jai Hiremath is the founder and executive chairman of Hikal.
– What business is Hikal involved in?
Hikal is in the business of pharmaceutical services.
Conclusion
I hope that after reading the article on Hikal Share Price Target for 2026, 2027, 2028, 2029, and 2030, you have a good understanding of the kind of performance we might see in the company’s growth. If you still have any questions related to this article, don’t forget to mention them in the comments. Stay connected with Market in India for important information about such stocks in the stock market.
Also read:-